WHO South-East Asia Journal of Public Health
  • 505
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 

    Article Cited by others

LETTER

Helpline facility to assist reporting of adverse drug reactions in India

Kalaiselvan Vivekanandan, Mishra Prabhakar, Singh Gyanendra N

Year : 2014| Volume: 3| Issue : 2 | Page no: 194-194

   This article has been cited by
 
1 Materiovigilance: Concept, Structure and Emerging Perspective for Patientís Safety in India
Farazul Hoda,Rishabh Verma,Mawrah Arshad,Ali Nasir Siddiqui,Mohammad Ahmed Khan,Mohammad Akhtar,Abul Kalam Najmi
Drug Research. 2020; 70(09): 429
[Pubmed]  [Google Scholar] [DOI]
2 Implementation of adverse event reporting for medical devices, India
Shatrunajay Shukla,Madhur Gupta,Sabitri Pandit,Milu Thomson,Abhimanyu Shivhare,Vivekanandan Kalaiselvan,Gyanendra Nath Singh
Bulletin of the World Health Organization. 2020; 98(3): 206
[Pubmed]  [Google Scholar] [DOI]
3 Medicine Safety Monitoring in Pediatric Population in India
Ismeet Kaur,Vivekanandan Kalaiselvan,Gyanendra N. Singh
The Indian Journal of Pediatrics. 2016; 83(5): 479
[Pubmed]  [Google Scholar] [DOI]
4 Reporting of adverse drug reactions due to cardiovascular drugs in India: A national duty
Vivekanandan Kalaiselvan,Ismeet Kaur,Vipin Kumar,Gyanendra N. Singh
Indian Heart Journal. 2015; 67(6): 613
[Pubmed]  [Google Scholar] [DOI]
5 System of adverse drug reactions reporting: What, where, how, and whom to report?
Vivekanandan Kalaiselvan,Pranay Kumar,Prabhakar Mishra,Gyanendra Singh
Indian Journal of Critical Care Medicine. 2015; 19(9): 564
[Pubmed]  [Google Scholar] [DOI]
6 Self-Reporting of Adverse Drug Reactions in Iraqi Hospitals: Patientís Perspectives
Kadhim Ali Kadhim
Pharmacology & Pharmacy. 2015; 06(12): 566
[Pubmed]  [Google Scholar] [DOI]

 

Read this article